Quin-C7
Quin-C7 is an orally active FPR2/ALX antagonist. Quin-C7 has anti-inflammatory activity and can ameliorate DSS (HY-116282) -induced colitis in mice. Quin-C7 can be used in the research of inflammatory bowel disease[1].
Product Specifications
CAS Number
[871100-12-8]
UNSPSC
12352005
Target
Formyl Peptide Receptor (FPR)
Related Pathways
GPCR/G Protein
Field of Research
Metabolic Disease; Inflammation/Immunology
Concentration
10mM
Purity
99.76
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
CCCCOC1=CC=C(C=C1)C(=O)NN1C(NC2=CC=CC=C2C1=O)C1=CC=C(O)C=C1
Molecular Formula
C25H25N3O4
Molecular Weight
431.48
References & Citations
[1]Yang WS, et al. Oral FPR2/ALX modulators tune myeloid cell activity to ameliorate mucosal inflammation in inflammatory bowel disease. Acta Pharmacol Sin. 2025 Mar 11.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
